Form D · Pharmaceuticals
HORIZON THERAPEUTICS INC
Northbrook, IL · CIK 0001453176
Offering snapshot reported Mar 17, 2010 · SEC filing
- Reported sold
- $8M Offering amount: $9M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 17, 2010 | Initial | $8,000,235 | No comparison | 26 | SEC filing |
| Mar 16, 2010 | Amendment | $17,000,000 | $5,000,000vs Jul 22, 2009 | 7 | SEC filing |
| Jul 22, 2009 | Amendment | $12,000,000 | No comparison | 7 | SEC filing |
| Dec 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-125618
Series D Preferred Stock financing.
Source: Form D, filed Mar 17, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey W. Bird | Director |
| Louis C. Bock | Director |
| Robert J. De Vaere | Director, Executive |
| Barry L. Golombik | Promoter |
| Jeff Himawan | Director |
| Jeffrey W. Sherman | Executive |
| George F. Tidmarsh | Director |
| Timothy P. Walbert | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1033 Skokie Blvd., Suite 355
Northbrook, IL, 60062
Northbrook, IL, 60062